BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25212506)

  • 1. CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach.
    Cao X; Cao D; Jin M; Jia Z; Kong F; Ma H; Wang Y; Jiang J
    BMC Gastroenterol; 2014 Sep; 14():157. PubMed ID: 25212506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44/CD24 expression in recurrent gastric cancer: a retrospective analysis.
    Yong CS; Ou Yang CM; Chou YH; Liao CS; Lee CW; Lee CC
    BMC Gastroenterol; 2012 Jul; 12():95. PubMed ID: 22839505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological and prognostic importance of CD44(+) /CD24(+) /EpCAM(+) expression in clinical pancreatic cancer.
    Ohara Y; Oda T; Sugano M; Hashimoto S; Enomoto T; Yamada K; Akashi Y; Miyamoto R; Kobayashi A; Fukunaga K; Morishita Y; Ohkohchi N
    Cancer Sci; 2013 Aug; 104(8):1127-34. PubMed ID: 23679813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CD44⁻/CD24⁺ phenotype is a poor prognostic marker in early invasive breast cancer.
    Ahmed MA; Aleskandarany MA; Rakha EA; Moustafa RZ; Benhasouna A; Nolan C; Green AR; Ilyas M; Ellis IO
    Breast Cancer Res Treat; 2012 Jun; 133(3):979-95. PubMed ID: 22119938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
    Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
    Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
    Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.
    Xu XY; Gou WF; Yang X; Wang GL; Takahashi H; Yu M; Mao XY; Takano Y; Zheng HC
    Tumour Biol; 2012 Dec; 33(6):1845-54. PubMed ID: 22948776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment.
    Wei HJ; Yin T; Zhu Z; Shi PF; Tian Y; Wang CY
    Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):428-34. PubMed ID: 21813394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD24 genetic variants contribute to overall survival in patients with gastric cancer.
    Jia ZF; Wang LZ; Cao XY; Wang C; Cao DH; Wu X; You LL; Jin MS; Wang YP; Zhou BS; Jiang J
    World J Gastroenterol; 2016 Feb; 22(7):2373-82. PubMed ID: 26900300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
    Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
    Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
    Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
    Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis.
    Durko L; Wlodarski W; Stasikowska-Kanicka O; Wagrowska-Danilewicz M; Danilewicz M; Hogendorf P; Strzelczyk J; Malecka-Panas E
    Dis Markers; 2017; 2017():3276806. PubMed ID: 28659655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction.
    Huang M; Li Y; Zhang H; Nan F
    J Exp Clin Cancer Res; 2010 Jun; 29(1):80. PubMed ID: 20569497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer.
    Setälä L; Lipponen P; Tammi R; Tammi M; Eskelinen M; Alhava E; Kosma VM
    Histopathology; 2001 Jan; 38(1):13-20. PubMed ID: 11135041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expressions of CD133 and CD44 in gastric adenocarcinoma and their relationship with E-cadherin expression].
    Lu G; Wu X; Zhou L; Yu L; Wu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1632-7. PubMed ID: 24273267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are CD44
    Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
    Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance.
    Ghaffarzadehgan K; Jafarzadeh M; Raziee HR; Sima HR; Esmaili-Shandiz E; Hosseinnezhad H; Taghizadeh-Kermani A; Moaven O; Bahrani M
    World J Gastroenterol; 2008 Nov; 14(41):6376-81. PubMed ID: 19009655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-mediated CD24 expression is correlated with gastric cancer aggressiveness by promoting cell migration and invasion.
    Fujikuni N; Yamamoto H; Tanabe K; Naito Y; Sakamoto N; Tanaka Y; Yanagihara K; Oue N; Yasui W; Ohdan H
    Cancer Sci; 2014 Nov; 105(11):1411-20. PubMed ID: 25174257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.